Aurobindo receives FDA approval for ritonavir tablets
EAST WINDSOR, N.J. — Pharma Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for ritonavir tablets USP, 100 mg. Aurobindo’s ritonavir tablets are an AB-rated generic equivalent to the reference listed drug, AbbVie Inc.’s Norvir. Ritonavir is in a class of medications called protease inhibitors. Protease
